IP Verse

Pinsent Masons patent opposition analysis

The comprehensive analysis of Pinsent Masons opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Pinsent Masons

Patent Number	Title	Applicant	Opposition Date	Opposition Company
EP4321157	New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)	NOVARTIS	Jul 23, 2025	LANYON OPPOSITIONS
EP3853305	High-Purity Peg Lipids And Uses Thereof	MODERNA	Jul 2, 2025	LANYON OPPOSITIONS
EP4241849	Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor Pertuzumab	F HOFFMANN LA ROCHE	Jun 17, 2025	LANYON OPPOSITIONS
EP3589661	Adjuvant Treatment Of Her2-Positive Breast Cancer	F HOFFMANN LA ROCHE	Jul 31, 2024	LANYON OPPOSITIONS
EP3703818	Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist	REGENERON PHARMACEUTICALS	Jul 30, 2024	LANYON OPPOSITIONS
EP3626270	New Use	NOVARTIS	Jul 11, 2024	LANYON OPPOSITIONS
EP3294283	Sacubitril-Valsartan Dosage Regimen For Treating Heart Failure	NOVARTIS	Dec 7, 2023	STRAWMAN
EP3597659	Prevention Of Disulfide Bond Reduction During Recombinant Production Of Polypeptides	GENENTECH	Nov 29, 2023	STRAWMAN

Top companies who are the clients of Pinsent Masons

Company	Total
LANYON OPPOSITIONS	6
STRAWMAN	2